50 mg lyophilised · single compound
$205.00 CAD
SS-31 is a small peptide that targets the mitochondria - the cell's power plants - and is studied in research on energy production and oxidative stress. Laboratory work focuses on how it supports mitochondrial function.
For laboratory and research use only - not for human consumption.
Checking the live COA archive for the newest lot documentation.
Use the verification archive to select a peptide name and review all published lot records alphabetically.
View previous lab resultsSS-31 (also called elamipretide) is a mitochondria-targeting tetrapeptide (a four-amino-acid chain) that homes in on the inner membrane of mitochondria (the cell’s energy “power plants”) and binds a lipid there called cardiolipin.
Studied for mitochondrial bioenergetics (how cells make energy) and oxidative stress (damage from reactive molecules), across conditions from heart failure to rare mitochondrial diseases. It has generally been well tolerated in clinical studies of several mitochondrial disorders.
By binding cardiolipin, SS-31 is thought to stabilise the folded inner-membrane structure (cristae) of mitochondria, reduce harmful reactive oxygen species, and support ATP production (the cell’s energy currency).
Elamipretide received FDA accelerated approval in September 2025 (brand name Forzinity) for the ultra-rare genetic disorder Barth syndrome; for all other uses it remains investigational. The material here is an unapproved research compound, not that medicine, and not for human consumption.
A single vial containing 50 mg of SS-31 as a lyophilised powder.
